Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Oncotarget|January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three casesAndrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody DeficiencyAndrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
British Journal of Haematology|May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimensAndrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology|January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experienceMattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
BMC Cancer|October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell deathFrancesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Hematological Oncology|September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literatureAndrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
Cancer Cell International|January 26, 2025
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancerElena Lastraioli, Jessica Iorio, Francesco Piazza, et al.
Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Pageof 18